IAK (IAK) Stock Price & Analysis
IAK (IAK) fell 1.15% to USD 143.88 as of September 8, 2026 at 16:06 UTC, according to Nexqual real-time market data.
IAK last closed at USD 143.88; the session ranged USD 143.49–144.56 on volume of 18,371 shares. Market capitalization is —, with a 52-week range of USD 124.62–152.38 (PCX). Source: Nexqual, September 8, 2026 at 16:06 UTC.
Key Statistics (as of September 8, 2026 at 16:06 UTC)
| Price | USD 143.88 |
|---|---|
| Change | ▼ 1.15% (down) |
| Previous Close | USD 143.88 |
| Open | USD 143.88 |
| Day Range | USD 143.49 – 144.56 |
| 52-Week Range | USD 124.62 – 152.38 |
| Volume | 18,371 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (IAK)
Nexqual's technical model rates IAK "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 16:06 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 47.15 (neutral) |
| vs SMA50 | Below (USD 145.84) |
| MACD | -0.09 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IAI | iShares U.S. Broker-Dealers & S | USD 194.7 | ▼ 1.7% |
| KIE | State Street SPDR S&P Insurance | USD 62.98 | ▼ 2.82% |
| IAT | iShares U.S. Regional Banks ETF | USD 62.64 | ▼ 0.59% |
| IYG | iShares U.S. Financial Services | USD 97.19 | ▼ 1.44% |
| IHE | iShares U.S. Pharmaceutical ETF | USD 102.64 | ▼ 2.64% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 16:06 UTC. This page is informational and not investment advice.